Literature DB >> 24091903

The role of ECT in suicide prevention.

Max Fink1, Charles H Kellner, W Vaughn McCall.   

Abstract

Suicide is a leading cause of death among psychiatric patients, and a leading cause of death from all causes in people younger than 30 years. The rapid relief of severe depression, mania, and psychosis by electroconvulsive therapy (ECT) is accompanied by the rapid reduction in suicide drive. Electroconvulsive therapy use is, however, inhibited by fear of electricity, unreasoned prejudice, legislative restrictions, and the limited availability of trained professionals and adequate facilities. This review assesses the experience with ECT in persons with suicide risk and recommends the consideration of ECT in treatment algorithms to reduce suicide rates.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24091903     DOI: 10.1097/YCT.0b013e3182a6ad0d

Source DB:  PubMed          Journal:  J ECT        ISSN: 1095-0680            Impact factor:   3.635


  32 in total

1.  "Does Ketamine Have Rapid Anti-Suicidal Ideation Effects?"

Authors:  Laili Soleimani; Alison Welch; James W Murrough
Journal:  Curr Treat Options Psychiatry       Date:  2015-10-16

Review 2.  Suicide Risk Assessment and Prevention: Challenges and Opportunities.

Authors:  Eileen P Ryan; Maria A Oquendo
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-04-23

3.  Cost-effectiveness of Electroconvulsive Therapy vs Pharmacotherapy/Psychotherapy for Treatment-Resistant Depression in the United States.

Authors:  Eric L Ross; Kara Zivin; Daniel F Maixner
Journal:  JAMA Psychiatry       Date:  2018-07-01       Impact factor: 21.596

Review 4.  On the significance of electroconvulsive therapy in the treatment of severe mental diseases.

Authors:  Michael Grözinger; Elke Stefanie Smith; Andreas Conca
Journal:  Wien Klin Wochenschr       Date:  2015-03-03       Impact factor: 1.704

Review 5.  Does ketamine have anti-suicidal properties? Current status and future directions.

Authors:  Rebecca B Price; Sanjay J Mathew
Journal:  CNS Drugs       Date:  2015-03       Impact factor: 5.749

6.  A two-site, open-label, non-randomized trial comparing Focal Electrically-Administered Seizure Therapy (FEAST) and right unilateral ultrabrief pulse electroconvulsive therapy (RUL-UBP ECT).

Authors:  Gregory L Sahlem; William V McCall; E Baron Short; Peter B Rosenquist; James B Fox; Nagy A Youssef; Andrew J Manett; Suzanne E Kerns; Morgan M Dancy; Laryssa McCloud; Mark S George; Harold A Sackeim
Journal:  Brain Stimul       Date:  2020-07-29       Impact factor: 8.955

Review 7.  Suicide and suicidal behaviour.

Authors:  Gustavo Turecki; David A Brent
Journal:  Lancet       Date:  2015-09-15       Impact factor: 79.321

Review 8.  Psychopharmacological Agents and Suicide Risk Reduction: Ketamine and Other Approaches.

Authors:  Rayan K Al Jurdi; Alan Swann; Sanjay J Mathew
Journal:  Curr Psychiatry Rep       Date:  2015-10       Impact factor: 5.285

9.  Electroconvulsive Therapy in Women: A Retrospective Study from a Mental Health Hospital in Turkey.

Authors:  Armağan Özdemir; Cana Aksoy Poyraz; Evrim Erten; Emre Çırakoğlu; Nesrin Tomruk
Journal:  Psychiatr Q       Date:  2016-12

Review 10.  Bipolar Disorder and Suicide: a Review.

Authors:  Jacob N Miller; Donald W Black
Journal:  Curr Psychiatry Rep       Date:  2020-01-18       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.